3-Hydroxy-N-Methyl-3-Phenyl-Propylamine

We are 3-Hydroxy-N-Methyl-3-Phenyl-Propylamine CAS:42142-52-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:     3-Hydroxy-N-Methyl-3-Phenyl-Propylamine
CAS.NO: 42142-52-9
Synonyms:
3-Hydroxy-N-methyl-3-phenyl-propylamine
3-(Methylamino)-1-phenylpropan-1-ol
α-[2-(MethylaMino)ethyl]benzyl Alcohol
3-Hydroxy-N-methyl-3-phenylpropylamine
3-(Methylamino)-1-phenylpropanol

Molecular Formula:C10H15NO
Molecular Weight: 165.23200

Physical and Chemical Properties:
Density: 1.017 g/cm3
Boiling point: 170 °C / 31mmHg
Melting point: 64 °C
Flash point: 114.8±16.0 °C
Refractive index: 1.531

Specification:
Appearance: White crystalline powder
Purity:≥99%
Water:≤0.5%
Residue on ignition:≤0.1%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Fluoxetine hydrochloride CAS:59333-67-4
Intermediates of Atomoxetine hydrochloride CAS:82248-59-7

3-Hydroxy-N-Methyl-3-Phenyl-Propylamine


Related News: Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.Dimetoxi (metil) (3,3,3-trifluoropropil) silano CAS:358-67-8 The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises.149490-60-8 Active pharmaceutical ingredients directly impact disease.Diallylamine CAS:124-02-7 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies.

Related Products
Product Name
3-Ethylphenylboronic acid View Details
2-Chloro-4-bromo-5-fluorobenzaldehyde View Details
Diethylaminomethylmethyldiethoxysilane View Details
4′-N-OCTYLACETOPHENONE manufacturer 2,4,5-Trifluorobenzoic acid manufacturer N-Methyl-1-naphthalenemethylamine hydrochloride manufacturer 2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile manufacturer Serinol manufacturer